ZyVersa Therapeutics, Inc. ZVSA
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 302.70K | 101.80K | 528.00K | 72.10K | 1.61M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 439.60K | 231.60K | 298.20K | 378.70K | 498.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 14.50K | 169.40K | 98.20K | -- |
| Total Current Assets | 742.20K | 347.90K | 995.50K | 549.10K | 2.11M |
|
|
|||||
| Total Current Assets | 742.20K | 347.90K | 995.50K | 549.10K | 2.11M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 18.65M | 18.65M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 44.70K | 444.10K | 227.30K |
| Total Assets | 742.20K | 347.90K | 1.04M | 19.64M | 20.99M |
|
|
|||||
| Total Accounts Payable | 10.24M | 10.12M | 9.81M | 9.77M | 9.60M |
| Total Accrued Expenses | 3.21M | 2.55M | 2.89M | 2.91M | 2.39M |
| Short-term Debt | 1.20M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 220.60K | 64.50K | 70.00K | 7.30K | 7.30K |
| Total Other Current Liabilities | 220.60K | 64.50K | 70.00K | 7.30K | 7.30K |
| Total Current Liabilities | 14.87M | 12.73M | 12.77M | 12.69M | 12.00M |
|
|
|||||
| Total Current Liabilities | 14.87M | 12.73M | 12.77M | 12.69M | 12.00M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.20M | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 851.70K | 851.70K |
| Total Liabilities | 14.87M | 12.73M | 12.77M | 13.54M | 12.86M |
|
|
|||||
| Common Stock & APIC | 125.26M | 125.21M | 125.19M | 123.21M | 123.03M |
| Retained Earnings | -139.38M | -137.58M | -136.91M | -117.10M | -114.89M |
| Treasury Stock & Other | -7.20K | -7.20K | -7.20K | -7.20K | -7.20K |
| Total Common Equity | -14.12M | -12.39M | -11.73M | 6.10M | 8.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
|
|||||
| Total Common Equity | -14.12M | -12.39M | -11.73M | 6.10M | 8.13M |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.12M | -12.39M | -11.73M | 6.10M | 8.13M |
|
|
|||||